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The process of IgE switching requires the prior transcription of
the unrearranged Ce gene, which leads to its recombination
with the VDJ region. The activation of NF-jB by CD40 is a key
process in facilitating this transcription by promoting the ac-
tivation of the Ce promoter. The present study explores the
uncharacterized signalling pathways employed by CD40 in
activating NF-jB by the overexpression of genes encoding wild-
type and dominant-negative forms of the signalling components
tumour-necrosis-factor-receptor-associated factor 6 (TRAF-6),
NF-jB-inducing kinase (NIK), IjB kinase (IKK)-1 and IKK-2
in the BJAB B-cell line. The overexpression of TRAF-6 or NIK
was sufficient to activate NF-jB and the Ce promoter, whereas
their dominant-negative counterparts decreased the ability of
INTRODUCTION
Antibody isotype switching in B-cells is characterized by a
deletional recombination event in which the VDJ gene segment
is joined to a different heavy chain C region (C
H
) gene [1]. This
switch recombination results in the production of an antibody
with a different heavy-chain isotype but with the original antigen
specificity. Because the C
H
region dictates the functional capa-
bilities of an antibody, isotype switching is crucial in exploiting
the various effector functions of the immune system. The process
of switch recombination occurs between switch (S) regions
located upstream of each C
H
gene, except Cl. However, the
transcription of a particular germline (unrearranged) C
H
gene is
a prerequisite for switch recombination to that specific C
H
gene
[2–5]. Such transcription yields a sterile germline transcript
starting at the I exon, upstream of the S region, and continuing
through the S region and C
H
gene [6]. The S region is removed
by splicing, resulting in the joining of the I exon and the C
H
region. Because the germline transcripts are key components in
the targeting of switch recombination, much interest has focused
on the mechanisms controlling their transcription. The latter is
controlled primarily via the modulation of the activity of the
proximal promoters in the C
H
genes by transcription factors. In
isotype switching to IgE, which is central to the generation of
allergic states, the induction of germline transcripts from the
unrearranged Ce gene is facilitated primarily by the concerted
binding of the transcription factors STAT-6 and NF-jB to their
cognate binding sites in the Ce promoter [7–9]. The activities of
these two transcription factors are regulated by two extracellular
signals [8]. Interleukin 4 (IL-4), which is secreted by T lympho-
cytes, activates STAT-6 via a well-characterized signal trans-
duction pathway [10–13]. The activation of NF-jB is achieved by
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CD40 to activate NF-jB and the Ce promoter. The over-
expression of wild-type IKK-1 or IKK-2 seemed to cause toxic
effects on the cells, whereas the dominant-negative forms were
selective in their blockade of NF-jB and the Ce promoter. These
results suggest that CD40 employs TRAF-6, which presumably
recruits NIK, which in turn employs IKK-1}IKK-2 to activate
NF-jB and the Ce promoter, the prologue to IgE switching.
Thus the findings define a crucially important pathway in the
generation of allergic states.
Key words: allergy, B-cells, kinases, nuclear factor jB, signal
transduction.
the cognate recognition of the B-cell membrane protein CD40
and the T-cell membrane CD40 ligand (CD40L) [8,14]. The
central role of CD40L–CD40 interaction in B-cell isotype switch-
ing was initially demonstrated in hyper-IgM syndrome patients
who have a mutated CD40L gene, and also in mice having a
targeted disruption of the CD40L or CD40 gene. Hyper-IgM
syndrome patients [15] and mice lacking CD40L [16] or CD40
[17] do not undergo isotype switching. CD40 thus emerges as a
central component in regulating IgE production; the resolution
of its signal transduction pathway promises to provide a valuable
mode for controlling IgE synthesis.
The activation of NF-jB is a key step in mediating IgE
switching in response to CD40 because it promotes the induction
of germline transcripts from the unrearranged Ce gene, the
prerequisite to IgE switching. The importance of NF-jB is
emphasized by a study showing that NF-jB knock-out mice have
defects in IgE class switching [18]. Latent NF-jB is the pre-
dominant form in most cell types and it is rendered inactive in the
cytoplasm via its association with the IjB inhibitory proteins
[19]. The activation of NF-jB necessitates the dissociation of IjB
from NF-jB via serine phosphorylation [20] and subsequent
proteasomal [21] proteolysis of the IjB inhibitory subunit, thus
releasing an active NF-jB heterodimer that is translocated into
the nucleus [22,23]. The signal transduction pathway used by
CD40 in effecting the phosphorylation of the IjB forms in B-cells
is currently unclear. However, valuable clues might be provided
by the IL-1 and tumour necrosis factor (TNF) signal transduction
pathways because both of these cytokines activate NF-jB; the
signalling components used by both in activating NF-jB have
recently been delineated. The pathways initially recruit specific
members of the TNF-receptor-associated factor (TRAF) family.
The TNF pathway employs TRAF-2 [24], whereas TRAF-6 is
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recruited by the IL-1 receptor complex [25]. Both TRAF-2 and
TRAF-6 subsequently interact with and activate the NF-jB-
inducing kinase (NIK) [26,27]. The activated NIK in turn can
activate the two forms of IjB kinase (IKK), IKK-a}IKK-1 and
IKK-b}IKK-2, which phosphorylate IjB, permitting the trans-
location of active NF-jB into the nucleus [27–32]. The role of
these various signalling components in mediating the activation
of NF-jB by CD40 is currently unknown. It is known that the
cytoplasmic domain of CD40 can associate with various members
of the TRAF family, including TRAF-2 and TRAF-6 [33–35]. In
addition, reports have described a role for TRAF-2 in mediating
the activation of NF-jB by CD40 [24,36,37], but recent findings
have suggested that CD40 might activate NF-jB by a mechanism
independent of TRAF-2 [38]. TRAF-6 has recently gained
prominence as a crucial mediator of the activation of NF-jB by
CD40 [39] in mice that were deficient in TRAF-6, being defective
in CD40 signalling [40]. However, whereas TRAF-6 is a key early
signalling component in CD40 signalling, the identities of
the signalling components downstream of TRAF-6 remain to be
defined. The present work was therefore aimed at mapping the
CD40 signalling pathway from TRAF-6 to activation of NF-jB
in B-cells, with a view to exploring the contribution of the
components of this pathway to the induction of germline
transcripts from the unrearranged Ce gene, the prologue to IgE
switching. The findings confirm the crucial role of TRAF-6 in
mediating the activation of NF-jB by CD40 in B-cells, but also
define the involvement of the downstream signalling kinases,
NIK, IKK-1 and IKK-2 in the activation process. In addition,
the pathway formed from these components is also demonstrated
to be crucial in mediating the activation of the Ce promoter by
CD40, which leads to the induction of germline Ce transcripts
and ultimately to IgE production. This study thus resolves a
CD40 signal transduction pathway that is critical for IgE
switching and might be of great value in identifying novel targets
to exploit in our attempts to design innovative regimes to counter
unwanted allergic responses.
MATERIALS AND METHODS
Materials
RPMI 1640 medium, fetal calf serum (FCS) and Superscript II
reverse transcriptase were from Life Technologies (Paisley,
Renfrewshire, U.K.). Glutamine, streptomycin and HAT me-
dium (100 lM hypoxanthine}0.4 lM aminopterin}16 lM thymi-
dine) were from Sigma (Poole, Dorset, U.K.). Taq DNA poly-
merase, dNTPs, luciferase substrate and lysis buffer were from
Promega Corp. (Madison, WI, U.S.A.). RNA Isolator was
from Genosys Biotechnologies (Cambridge, U.K.). The FLAG
(FLAG being Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) Western de-
tection kit was from Stratagene (La Jolla, CA, U.S.A.). The anti-
NIK antibody was from Calbiochem-Novabiochem Corp. (San
Diego, CA, U.S.A.). The enhanced chemiluminescence devel-
opment reagent was from New England Biolabs (Beverly, MA,
U.S.A.). The Epstein–Barr-virus-negative human B-cell lymph-
oma cell line (BJAB) was a gift from Dr D. Walls (Dublin City
University, Dublin, Ireland). CD32-transfected fibroblasts
(A.T.C.C. no. CRL-10680) and the anti-CD40 were gifts from
Professor C. Borrebaeck (Department of Immunotechnology,
Lund University, Lund, Sweden). The e-luciferase reporter
plasmid (e-luc) consisted of the germline Ce promoter (the region
fi162 to ›53 relative to the first initiation site for germline e-
transcripts) ligated upstream of the luciferase reporter gene and
was a gift from Professor J. Stavnezer (University of Massa-
chusetts Medical School, Worcester, MA, U.S.A.). The NF-jB-
luciferase reporter plasmid (jB-luc) consisted of five copies of the
NF-jB consensus site cloned into the luciferase reporter construct
pGL3-Basic (Promega Corp.). pEGFP-N1 (in which EGFP
stands for enhanced green fluorescent protein) was from Clontech
Laboratories (Palo Alto, CA, U.S.A.). The expression vectors
encoding TRAF6-Flag, dominant-negative mutant TRAF6
(289–522)-Flag, NIK, dominant-negative mutant (D) NIK(KK-
AA), IKK1-Flag, dominant-negative mutant IKK1 (K44A)-
Flag, IKK2-Flag and dominant-negative mutant IKK2
(K44A)-Flag were obtained from Tularik (San Francisco, CA,
U.S.A.).
Cell culture
Human BJAB cells were cultured in RPMI 1640 medium
supplemented with 10% (v}v) FCS, 2 mM l-glutamine,
100 units}ml penicillin and 100 lg}ml streptomycin. CD32-
transfected fibroblasts (A.T.C.C. no. CRL-10680) were cultured
in RPMI 1640 supplemented with 10% (v}v) FCS, 2 mM
l-glutamine, 100 units}ml penicillin, 100 lg}ml streptomycin and
HAT medium supplement. Both cell types were grown at 37 °C
in a humidified air}CO
#
(19:1) atmosphere.
Transfection of BJAB cells and assay of expression of luciferase
reporter genes
Aliquots (250 ll) of BJAB cells (4‹10( cells}ml) [in RPMI 1640
medium supplemented with 10% (v}v) FCS, 2 mM l-glutamine,
100 units}ml penicillin and 100 lg}ml streptomycin] were mixed
on ice with 15 lg of the designated expression vectors, 5 lg of
pEGFP-N1 and 5 lg of jB-luc or e-luc and electroporated
(220 V, 960 lF) by means of a Bio-Rad Gene Pulser equipped
with a capacitance extender (Bio-Rad, Hercules, CA, U.S.A.).
The electroporated cells were subsequently added to fresh
medium (5 ml) and allowed to recover at 37 °C for 24 h in a
humidified air}CO
#
(19:1) atmosphere. Aliquots (2.5 ml) of
recovered cells were incubated in the absence or presence of anti-
CD40 monoclonal antibody (500 ng}ml) and recombinant hu-
man IL-4 (100 i.u.}ml) for 5 min at room temperature. Cells
were subsequently mixed with aliquots (750 ll ; 4‹10& cells}ml)
of CD32-transfected fibroblasts. Aliquots (250 ll) of the mixed
BJAB}fibroblast suspension were then seeded into 96-well plates
and incubated at 37 °C for a further 24 h. Cell extracts were then
generated and measured for luciferase activity by using a
luciferase assay system with reporter lysis buffer from Promega
Corporation.
Quantification of transfection efficiency
BJAB cells were electroporated as above and allowed to recover
at 37 °C for 48 h in a humidified air}CO
#
(19:1) atmosphere. The
cells were then centrifuged at 1450 g for 5 min, washed once in
PBS (5 ml) and finally resuspended in PBS (10’ cells}ml).
Transfection efficiency was measured by counting the number of
cells expressing the EGFP by using a FACStar Plus Flow
Cytometer (Becton Dickinson, Aalst, Belgium) with laser excita-
tion at 488 nm by using a 530 nm bandpass filter to collect the
green fluorescence.
Western immunoblotting of transfected cells
BJAB cells were electroporated as above and allowed to recover
at 37 °C for 24 h in a humidified air}CO
#
(19:1) atmosphere.
Aliquots of cells (1 ml; 2‹10’) were then centrifuged at 1450 g
for 5 min, washed once in PBS (1 ml) and finally lysed in
SDS}PAGE sample buffer (100 ll) [50 mM Tris}HCl buffer, pH
6.8, containing 2% (w}v) SDS, 10% (v}v) glycerol, 1% (v}v)
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2-mercaptoethanol and 0.1% (w}v) Bromophenol Blue]. The
lysates were sonicated for 10 s to decrease sample viscosity and
then heated to 90 °C for 5 min. Lysates were cleared of particulate
material by centifugation at 20000 g for 5 min. Aliquots (25 ll)
of the clear supernatants were subjected to SDS}PAGE [6%
(w}v) gel] and the separated proteins were transferred elec-
trophoretically from the gels to nitrocellulose. The nitrocellulose
was then probed for FLAG expression by using the alkaline
phosphatase-based FLAG Western detection kit in accordance
with the manufacturer’s instructions. The expression of NIK was
detected by probing the nitrocellulose with a rabbit polyclonal
anti-NIK antibody (1:350 dilution) ; detection was with an
enhanced chemiluminescence system, used in accordance with
the manufacturer’s instructions.
RNA extraction and reverse transcriptase-mediated PCR (RT-PCR)
Aliquots (2.5 ml) of untransfected BJAB cells (4‹10’ cells}ml)
were stimulated in the absence or presence of anti-CD40 mono-
clonal antibody and IL-4, as described above. Total cellular
RNA was prepared by using the RNA Isolator in accordance
with the manufacturer’s instructions. First-strand cDNA syn-
thesis was performed with Superscript II reverse transcriptase
and random oligonucleotide primers ; PCR amplification was
performed with Taq DNA polymerase and primers to amplify
selectively regions of the Ce and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) cDNA species. The sequences of the
forward and reverse oligonucleotide primers and the sizes of
the products were as follows: Ce, 5«-CGTCTCGGGTGC-
GTGGGC-3«, 5«-CAGGTGATCGTGGGCGACT-3«, 500 bp;
GAPDH, 5«-ACCACAGTCCATGCCATC-3«, 5«-TCCACCA-
CCCTGTTGCTG-3«, 452 bp. The forward and reverse Ce
primers were designed to hybridize within the first and third
exons of the Ce region [41] respectively. Amplification parameters
were as follows: step 1, 30 cycles at 94 °C for 1 min, at 53 °C for
1 min and at 72 °C for 1 min; step 2, at 72 °C for 10 min. The
PCR products were subjected to electrophoresis on a 1.5% (w}v)
agarose gel containing ethidium bromide, then photographed.
RESULTS AND DISCUSSION
To probe the signalling components that are employed by CD40
in its activation of NF-jB and induction of germline Ce tran-
scripts in B-cells, the Epstein–Barr-virus-negative human B-cell
lymphoma cell line BJAB was used as a model for naive B-cells.
This cell line has been characterized as a valuable model system
for exploring the regulation of expression of germline Ce tran-
scripts [42]. The process of IgE switching requires the dual
signals of IL-4 and activation of CD40; this was achieved by
treating the BJAB cells with exogenous human recombinant
IL-4 and an agonistic anti-CD40 antibody adsorbed on CD32-
transfected fibroblasts. The latter has been shown to be an
effective means of cross-linking and activating CD40 [43]. The
efficacy of the anti-CD40 antibody in the present model system
was initially examined by assessing its capacity, in conjunction
with IL-4, to activate the promoter controlling the expression of
the Ce germline transcripts. The activity of the Ce promoter was
determined by measuring the expression of a transfected luci-
ferase gene ligated downstream of the Ce promoter (e-luc) [8].
BJAB cells, in the absence of stimulation by IL-4 and CD40, but
in the presence of various amounts of isotype antibody control
for the anti-CD40 antibody, displayed basal expression of
luciferase ; any induction above this level is depicted as fold
induction. The anti-CD40 antibody caused a dose-dependent
activation of the Ce promoter as demonstrated by an induction
Figure 1 Dose-dependent activtion of the Ce promoter by agonistic anti-
CD40 antibody in BJAB B-cells
BJAB cells (107) were electroporated with e-luc (5 lg), a plasmid encoding a luciferase reporter
gene regulated by the Ce promoter. Electroporated cells were subsequently incubated for 24 h
in the absence (fi) and the presence (›) of IL-4 (100 units/ml) and various concentrations of
anti-CD40 antibody (500 ng/ml) adsorbed on CD32-transfected fibroblasts. Unstimulated
control cells (fi) were treated with equivalent concentrations of isotype control antibody. Cell
extracts were measured for luciferase activity and the results are expressed as fold induction
of luciferase relative to cells that were incubated in the absence of IL-4 and anti-CD40 antibody.
Results are means‡S.E.M. for four independent experiments.
of e-luc (Figure 1). Maximal induction was apparent with the
highest anti-CD40 dose (500 ng}ml). It was not practically
feasible to assess the effect of higher concentrations of the
antibody, so 500 ng}ml was employed for all further experiments.
Attempts were then made to assess the ability of the combined
treatment of IL-4 and anti-CD40 to induce IgE in BJAB cells.
The two agents failed to induce detectable levels of IgE, as
measured by a sandwich-based ELISA system for human IgE
with a sensitivity limit in the pg}ml range (results not shown).
However, the more sensitive approach of RT-PCR was used to
show that the combined treatment of IL-4 and anti-CD40 induced
the expression of germline Ce transcripts (Figure 2). The tran-
scripts were assayed by RT-PCR by using primers to amplify the
region within the first and third exons of the Ce gene [41].
The splicing of the intervening introns forms germline transcripts
with a predicted size of 500 bp when amplified with the described
RT-PCR protocol. The stimulation of BJAB cells with IL-4 and
anti-CD40 generated increased levels of this product (Figure 2).
As a control for the RT-PCR assay, primers were also used to
amplify a 452 bp region of the housekeeping GAPDH gene. Both
samples showed comparable levels of the resulting PCR product,
thus confirming that the effects of IL-4 and anti-CD40 are
selective for induction of the Ce transcripts. This confirms a
previous finding [42] and importantly validates the BJAB cell line
as a suitable paradigm for probing the early stages of IgE
switching.
The identity of the signalling components that mediate the
activation ofNF-jBbyCD40 inBJAB cells was initially explored.
The activity of NF-jB was determined by measuring the in-
duction of a transfected NF-jB-regulated luciferase gene (jB-
luc) ; the potential role of signalling molecules was assessed by
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Figure 2 Induction of Ce germline transcripts by IL-4 and engagement of
CD40 in BJAB B-cells
BJAB cells (4‹106) were stimulated in the absence (Con) and presence of IL-4 (100 units/ml)
and anti-CD40 antibody (500 ng/ml), after which total cellular RNA was prepared and subjected
to first-strand cDNA synthesis with Superscript II reverse transcriptase and random
oligonucleotide primers. PCR amplification was performed with Taq DNA polymerase and
primers to selectively amplify regions of the Ce and GAPDH cDNA species. This resulted in the
generation of products with predicted sizes of 500 and 452 bp respectively. A base pair ladder
(L) was used to calculate the sizes of the products.
determining the effects of co-transfected wild-type or dominant-
negative forms of TRAF-6, NIK, IKK-1 and IKK-2 on the
expression of jB-luc. However, before exploring the functional
consequences of expressing wild-type and dominant-negative
forms of these components, it was first necessary to confirm the
overexpression of the various signalling components. This was
achieved by a Western immunoblotting analysis of extracts from
transfected cell populations (Figure 3). The wild-type and domi-
nant-negative forms of TRAF-6, IKK-1 and IKK-2 had been
tagged with a FLAG epitope, permitting their detection with an
anti-FLAG detection system, whereas the expression of the two
forms of NIK, which lacked the FLAG epitope tag, was detected
with an anti-NIK antibody. This analysis confirmed the over-
expression of both forms of the four signalling components.
Each component displayed an electrophoretic mobility consistent
with its predicted molecular mass. The dominant-negative form
of TRAF-6 is considerably smaller than its wild-type counterpart
because the former was generated by the deletion of a region at
the N-terminal domain of wild-type TRAF-6. The dominant-
negative forms of NIK, IKK-1 and IKK-2 were derived by point
mutations; their electrophoretic mobilities are therefore com-
parable with their wild-type equivalents. The demonstrable
expression of the various signalling molecules facilitated an
exploration of their potential roles in CD40 signalling in B-cells.
The role of TRAF-6 in mediating the activation of NF-jB by
CD40 in B-cells was initially examined (Figure 4). The over-
expression of wild-type TRAF-6 caused the induction of jB-luc
even in the absence of stimulation by CD40. This indicates that
activation of TRAF-6, which is achieved by overexpression, is a
sufficient stimulus to activate NF-jB in B-cells. This has pre-
viously been observed in other cell types [39]. The activation by
TRAF-6 seems to represent a maximum level, because CD40 did
Figure 3 Overexpression of wild-type and dominant-negative forms of
NF-jB signalling components in BJAB B-cells
BJAB cells (107) were electroporated with expression vectors (15 lg of DNA) encoding wild-
type and dominant-negative forms of TRAF-6, NIK, IKK-1 and IKK-2 and allowed to recover
overnight at 37 °C. Whole cell lysates were subsequently prepared in SDS/PAGE sample buffer,
subjected to SDS/PAGE [4% (w/v) gel] and electroblotted to nitrocellulose membrane. (A) The
wild-type and dominant-negative forms of TRAF-6 (lanes 2 and 3 respectively), IKK-1 (lanes 4
and 5 respectively) and IKK-2 (lanes 6 and 7 respectively) were FLAG-tagged and were detected
with an anti-FLAG antibody in conjunction with an alkaline-phosphatase-based detection system.
Lane 1 contained an extract from cells that had been transfected with the empty expression
vector. (B) Both wild-type and dominant-negative forms of NIK (lanes 2 and 3 respectively)
were probed with a rabbit polyclonal anti-NIK antibody and were detected by enhanced
chemiluminescence. Lane 1 contained an extract from cells that had been transfected with the
empty expression vector. The arrows within the gels indicate the electrophoretic mobilities of
the various proteins. The positions of molecular mass markers are indicated on the left.
not significantly enhance the expression of jB-luc above this
level. The overexpression of the dominant-negative form of
TRAF-6 caused a marked inhibition of basal and CD40-induced
expression of jB-luc, confirming reports [39,40] of the crucial
role of TRAF-6 in mediating the activation of NF-jB by CD40.
This finding again justifies our experimental system as a suitable
model for exploring CD40 signalling in B-cells.
The role of lead candidate signalling molecules likely to act
downstream of TRAF-6 was investigated next. The over-
expression of wild-type NIK, like that of TRAF-6, was sufficient
to activate NF-jB, even in the absence of CD40, as demonstrated
by an increased expression of jB-luc. Indeed, NIK is considerably
more efficacious than TRAF-6 in its activation of NF-jB,
promoting it as a key regulator of NF-jB in B-cells. The greater
efficacy of NIK relative to TRAF-6 might suggest an additional
TRAF-6-independent mechanism for activating NIK. However,
the possibility cannot be excluded that the lower efficacy of
TRAF-6 is due to limiting endogenous levels of NIK. The
expression of the dominant-negative form of NIK blocked the
ability of CD40 to induce jB-luc. These findings thus indicate
that NIK is a necessary and sufficient mediator in the activation
of NF-jB by CD40. This suggests that, like the IL-1 receptor
system [25], CD40 triggers the activation of NF-jB by recruiting
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Figure 4 Effect of wild-type and dominant-negative forms of NF-jB
signalling components on the activation of NF-jB in BJAB cells
BJAB cells (107) were co-transfected by electroporation with an expression vector (15 lg of
DNA) encoding one of the wild-type (WT) or dominant-negative (D) forms of the various NF-
jB signalling components, together with a plasmid encoding constitutively expressed EGFP
(5 lg of DNA) and jB-luc (5 lg), a plasmid encoding a luciferase reporter gene regulated by
a promoter containing five copies of the NF-jB consensus site. Electroporated cells were
subsequently incubated for 24 h in the absence and the presence of IL-4 (100 units/ml) and anti-
CD40 antibody (500 ng/ml) adsorbed on CD32-transfected fibroblasts. Unstimulated cells were
treated with isotype control antibody (500 ng/ml). Cell extracts were measured for luciferase
activity and the results are expressed as fold induction of luciferase relative to unstimulated cells
that had been transfected, as above, with an empty expression vector. Results are means‡S.E.M.
for at least three independent experiments.
TRAF-6, which in turn activates NIK. Because NIK has
previously been shown to activate IKK-1 and IKK-2, the role of
the latter two kinases in CD40 signalling was examined. The
dominant-negative forms of IKK-1 and IKK-2 caused a signifi-
cant inhibition of basal expression and induction of jB-luc by
CD40. This demonstrates their key roles in the CD40 signalling
pathway, which effects the activation of NF-jB in B-cells.
Paradoxically, the wild-type forms of IKK-1 and IKK-2 also
caused an apparent inhibition of basal and induced expression of
jB-luc. However, such inhibition might result from toxic effects
of the overexpressed IKK-1 and IKK-2 on the BJAB cells. Clues
from the latter emerge from an assessment of the effects of the
various signalling components on the expression of a constitu-
tively expressed reporter gene, namelyEGFP. Such an experiment
was originally designed to control for the effects of the different
expression vectors on transfection efficiency. Cells transfected
with an empty expression vector exhibited an average transfection
efficiency of approx. 20%. This efficiency was comparable for all
other transfections involving the various expression vectors, with
the exception of those encoding the wild-type forms of IKK-1
and IKK-2. The transfection efficiency was decreased to
12% and 7% in the latter two cases respectively. The nature of
such a decrease is not currently apparent but might be due to toxic
effects on the BJAB cells. The amounts of wild-type IKK-1 and
IKK-2 expression vectors in the transfection process were
decreased to eliminate the effects on transfection efficiency.
These lower amounts failed to affect the activity of NF-jB
(results not shown), confirming that the inhibitory effects of wild-
type IKK-1 and IKK-2 on NF-jB are related to their non-
specific effects on transfection efficiency. Irrespective of the
mechanism, the effects of the IKKs on transfection efficiency are
dependent on their kinase activity because their catalytically
inactive dominant-negative forms fail to affect the transfection
Figure 5 Effect of wild-type and dominant-negative forms of NF-jB
signalling components on the activation of Ce promoter in BJAB cells
BJAB cells (107) were co-transfected by electroporation with an expression vector (15 lg of
DNA) encoding one of the wild-type (WT) or dominant-negative (D) forms of the various NF-jB
signalling components, together with a plasmid encoding constitutively expressed green
fluorescent protein (5 lg of DNA) and with e-luc (5 lg), a plasmid encoding a luciferase
reporter gene regulated by the Ce promoter. Electroporated cells were subsequently incubated
for 24 h in the absence or the presence of IL-4 (100 units/ml) and anti-CD40 antibody
(500 ng/ml) adsorbed on CD32-transfected fibroblasts. Unstimulated cells were treated with
isotype control antibody (500 ng/ml). Cell extracts were measured for luciferase activity and the
results are expressed as fold induction of luciferase relative to unstimulated cells that had been
transfected, as above, with an empty expression vector. Results are means‡S.E.M. for at least
three independent experiments.
efficiency. However, the role of NF-jB, which is presumably
activated by IKK-1 and IKK-2, in mediating the inhibitory
effects is questionable because the wild-type forms of TRAF-6
andNIK,which also activateNF-jB, fail to influence transfection
efficiency. Thus the basis of the non-selective inhibitory effects of
IKK-1 and IKK-2 on transfection efficiency awaits resolution.
However, the lack of influence of the other overexpressed
signalling components confirms their selective effects on the
expression of jB-luc. These studies indicate that CD40 activates
NF-jB in B-cells via a TRAF-6–NIK–IKK-1}IKK-2 pathway in
B-cells. The functional consequence of activating this pathway
in B-cells was investigated next.
The proposed key role of NF-jB in promoting IgE switching
by inducing Ce germline transcripts prompted an assessment of
the involvement of the above signalling components in the
induction of germline transcripts. This was performed with
the wild-type and dominant-negative forms as above but by
measuring their effects on the expression of e-luc (Figure 5). The
results mirrored closely the findings from the equivalent studies
with jB-luc in that the dominant-negative forms of TRAF-6,
NIK, IKK-1 and IKK-2 decreased the ability of CD40 to induce
the expression of e-luc. This demonstrates the key role for the
TRAF-6–NIK–IKK-1}IKK-2 pathway in mediating the induc-
tion of Ce germline transcripts. The wild-type forms of IKK-1
and IKK-2 again demonstrated unexpected inhibitory effects on
the expression of e-luc but this was related to their inhibitory
effects on transfection efficiency.
In summary, these findings identify a number of key com-
ponents with crucial roles in the CD40 signalling pathway in B-
cells. The stimulation of CD40 in B-cells leads to the engagement
of the sequential TRAF-6–NIK–IKK-1}IKK-2 pathway, result-
ing in the activation of NF-jB. The latter, in conjunction with an
IL-4 co-stimulus that activates STAT-6, induces the expression
of Ce germline transcripts. Because this process is a crucial
requirement for IgE switching, the present work identifies a
# 2000 Biochemical Society
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number of key targets that might be exploited in the development
of novel anti-allergy therapies.
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